An Extension Study to Assess Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-4)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04659174 |
Recruitment Status :
Completed
First Posted : December 9, 2020
Last Update Posted : November 29, 2023
|
Sponsor:
Karuna Therapeutics
Information provided by (Responsible Party):
Karuna Therapeutics
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | October 3, 2023 |
Actual Study Completion Date : | October 3, 2023 |